ad image

Organoids

1 / 1
Facilitating Organoid Production for Biopharmaceutical Applications
Cell Therapy

Facilitating Organoid Production for Biopharmaceutical Applications

Karen Weisinger, Ph.D.

Cell X Technologies

PAO-06-24-CL-12Jul 02, 2024
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

PAO-09-23-CL-02Sep 29, 2023
100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future
History of Innovation

100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future

John Yoshi Shyu, Ph.D.; John M. Tobin IV

Corning Life Sciences

PAO-05-23-CL-08May 30, 2023
Eliminating Immunosuppression in Regenerative Medicine
Regenerative Medicine

Eliminating Immunosuppression in Regenerative Medicine

iTolerance

PAO-04-22-R250-74Apr 29, 2022
Bringing 3D Organoid Models Into a High-Throughput Environment
Organoids

Bringing 3D Organoid Models Into a High-Throughput Environment

Elizabeth Abraham, Ph.D.; Dennis Plenker, Ph.D.; Hervé Tiriac, Ph.D.

Corning Life Sciences

PAO-11-21-CL-09Nov 11, 2021
Leveraging Organoids to Address Neurodegenerative Diseases
Brain Organoids

Leveraging Organoids to Address Neurodegenerative Diseases

OrganoTherapeutics

PAO-04-22-R221-66-400Apr 29, 2021
Disruptive Technologies in Life Sciences: Personalized Medicines
Personalized Medicines

Disruptive Technologies in Life Sciences: Personalized Medicines

Alejandro Montoya; Ben Josey, Ph.D.; Shabana Islam, Ph.D.; Hilary Sherman; Elizabeth Abraham, Ph.D.

Corning Life Sciences

PAP-Q4-20-CL-009Dec 09, 2020
Brain Organoids Could Speed Drug Development for Neurological Diseases
Drug Development

Brain Organoids Could Speed Drug Development for Neurological Diseases

Pharma's Almanac

PAO-M06-19-NI-016Jun 20, 2019
1 / 1